The global monkeypox vaccine market size reached US$ 75.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 251.5 Million by 2028, exhibiting a growth rate (CAGR) of 14.4% during 2023-2028. The growing international health organizations and government initiatives due to the increasing spread of infectious diseases, the accelerating number of awareness campaigns, and continuous advancements in personalized medicine are some of the major factors propelling the market.